Xiaomei Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xiaomei Zhang has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
Connie Lam
Sydney Infectious Diseases Institute (Sydney ID), Faculty of Medicine & Health, The University of Sydney, Sydney, New South Wales, Australia
4 shared publicationsTaryn Crighton
Centre for Infectious Diseases and Microbiology-Public Health, Westmead Hospital, Western Sydney Local Health District, Sydney, New South Wales, Australia
4 shared publicationsVitali Sintchenko
Sydney Infectious Diseases Institute (Sydney ID), Faculty of Medicine & Health, The University of Sydney, Sydney, New South Wales, Australia
4 shared publicationsBen J. Marais
3 shared publicationsElena Martinez
3 shared publicationsBen J Marais
Sydney Infectious Diseases Institute (Sydney ID), Faculty of Medicine & Health, The University of Sydney, Sydney, New South Wales, Australia
2 shared publications
Latest Publications
- Open Access
Amplicon-based targeted next generation sequencing (tNGS) for Mycobacterium tuberculosis - unpacking the ‘black box’
The WHO recently endorsed two commercial culture-free targeted next-generation sequencing (tNGS) assays for detecting drug resistant Mycobacterium tuberculosis. These proprietary tNGS platforms present a ‘black box’. We developed an in-house tNGS assay using Oxford Nanopore Technology sequencing to detect an expanded range of resistance mutations directly from clinical specimens. The assay targeted 44 genomic loci; hsp65 for Mycobacterium tuberculosis complex (MTBC) identification; 12 loci for MTBC lineage classification; and 31 drug resistance loci predicted resistance to 16 anti-TB drugs. In total, 98 amplicons were distributed across three PCR pools. Analytical sensitivity was assessed using M. tuberculosis H37Rv, and proof-of-concept performance was evaluated in 63 archived clinical specimen extracts and one ‘real-life’ sputum specimen in comparison with Illumina whole genome sequencing (WGS). All amplicons were successfully amplified and sequenced from M. tuberculosis H37Rv genomic DNA. At ≥100 genome copies/μL, 71.4% of amplicons met ≥20( mean depth across six replicates, including all loci for rifampicin, ethambutol, pyrazinamide, fluoroquinolone and bedaquiline resistance. In 63 clinical specimens, (90% of amplicons achieved a mean depth of (20( in specimens with IS6110 PCR cycle threshold (Ct) values ≤24. With Ct value ≤27 lineage classification was concordant with WGS in 94.7% (18/19) of specimens and drug-susceptibility prediction showed 94.7% (18/19) agreement with both phenotypic and genotypic (WGS) testing. In a single clinical case (Ct 26.5), lineage and resistance-associated mutations were accurately identified directly from sputum. The findings provide new insights into rapid culture-independent tNGS approaches for rapid M. tuberculosis drug resistance detection with lineage assignment.
Open AccessAmplicon-based targeted next generation sequencing (tNGS) for Mycobacterium tuberculosis - unpacking the ‘black box’
The WHO recently endorsed two commercial culture-free targeted next-generation sequencing (tNGS) assays for detecting drug resistant Mycobacterium tuberculosis. These proprietary tNGS platforms present a ‘black box’. We developed an in-house tNGS assay using Oxford Nanopore Technology sequencing to detect an expanded range of resistance mutations directly from clinical specimens. The assay targeted 44 genomic loci; hsp65 for Mycobacterium tuberculosis complex (MTBC) identification; 12 loci for MTBC lineage classification; and 31 drug resistance loci predicted resistance to 16 anti-TB drugs. In total, 98 amplicons were distributed across three PCR pools. Analytical sensitivity was assessed using M. tuberculosis H37Rv, and proof-of-concept performance was evaluated in 63 archived clinical specimen extracts and one ‘real-life’ sputum specimen in comparison with Illumina whole genome sequencing (WGS). All amplicons were successfully amplified and sequenced from M. tuberculosis H37Rv genomic DNA. At ≥100 genome copies/μL, 71.4% of amplicons met ≥20( mean depth across six replicates, including all loci for rifampicin, ethambutol, pyrazinamide, fluoroquinolone and bedaquiline resistance. In 63 clinical specimens, (90% of amplicons achieved a mean depth of (20( in specimens with IS6110 PCR cycle threshold (Ct) values ≤24. With Ct value ≤27 lineage classification was concordant with WGS in 94.7% (18/19) of specimens and drug-susceptibility prediction showed 94.7% (18/19) agreement with both phenotypic and genotypic (WGS) testing. In a single clinical case (Ct 26.5), lineage and resistance-associated mutations were accurately identified directly from sputum. The findings provide new insights into rapid culture-independent tNGS approaches for rapid M. tuberculosis drug resistance detection with lineage assignment.
- Open Access
- 20 March 2026
- Published by Elsevier in The Lancet Microbe
- Vol. 7 (5) , 101362
Molecular diagnostic tests for isoniazid-resistant tuberculosis: a scoping review
- 20 March 2026
- Published by Elsevier in The Lancet Microbe
- Vol. 7 (5) , 101362
Open AccessMolecular diagnostic tests for isoniazid-resistant tuberculosis: a scoping review
- 24 October 2023
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 61 (10) , e0048523
Genomic markers of drug resistance in Mycobacterium tuberculosis populations with minority variants
Minority variants of Mycobacterium tuberculosis harboring mutations conferring resistance can become dominant populations during tuberculosis (TB) treatment, leading to treatment failure. Our understanding of drug-resistant within-host subpopulations and the frequency of resistance-conferring mutations in minority variants remains limited. M. tuberculosis sequences recovered from liquid cultures of culture-confirmed TB cases notified between January 2017 and December 2021 in New South Wales, Australia were examined. Potential drug resistance-conferring minority variants were identified using LoFreq, and mixed populations of different M. tuberculosis strains (≥100 SNPs apart) were examined using QuantTB. A total of 1831 routinely sequenced M. tuberculosis strains were included in the analysis. Drug resistance-conferring minority variants were detected in 3.5% (65/1831) of sequenced cultures; 84.6% (55/65) had majority strains that were drug susceptible and 15.4% (10/65) had majority strains that were drug resistant. Minority variants with high-confidence drug resistance-conferring mutations were 1.5 times more common when the majority strains were drug resistant. Mixed M. tuberculosis strain populations were documented in 10.0% (183/1831) of specimens. Minority variants with high-confidence drug resistance-conferring mutations were more frequently detected in mixed M. tuberculosis strain populations (2.7%, 5/183) than in single strain populations (0.6%, 10/1648; P = 0.01). Drug-resistant minority variants require monitoring in settings that implement routine M. tuberculosis sequencing. The frequency with which drug-resistant minority variants are detected is likely influenced by pre-culture requirement. Culture-independent sequencing methods should provide a more accurate reflection of drug-resistant subpopulations.
- 24 October 2023
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 61 (10) , e0048523
Genomic markers of drug resistance in Mycobacterium tuberculosis populations with minority variants
Minority variants of Mycobacterium tuberculosis harboring mutations conferring resistance can become dominant populations during tuberculosis (TB) treatment, leading to treatment failure. Our understanding of drug-resistant within-host subpopulations and the frequency of resistance-conferring mutations in minority variants remains limited. M. tuberculosis sequences recovered from liquid cultures of culture-confirmed TB cases notified between January 2017 and December 2021 in New South Wales, Australia were examined. Potential drug resistance-conferring minority variants were identified using LoFreq, and mixed populations of different M. tuberculosis strains (≥100 SNPs apart) were examined using QuantTB. A total of 1831 routinely sequenced M. tuberculosis strains were included in the analysis. Drug resistance-conferring minority variants were detected in 3.5% (65/1831) of sequenced cultures; 84.6% (55/65) had majority strains that were drug susceptible and 15.4% (10/65) had majority strains that were drug resistant. Minority variants with high-confidence drug resistance-conferring mutations were 1.5 times more common when the majority strains were drug resistant. Mixed M. tuberculosis strain populations were documented in 10.0% (183/1831) of specimens. Minority variants with high-confidence drug resistance-conferring mutations were more frequently detected in mixed M. tuberculosis strain populations (2.7%, 5/183) than in single strain populations (0.6%, 10/1648; P = 0.01). Drug-resistant minority variants require monitoring in settings that implement routine M. tuberculosis sequencing. The frequency with which drug-resistant minority variants are detected is likely influenced by pre-culture requirement. Culture-independent sequencing methods should provide a more accurate reflection of drug-resistant subpopulations.
- Open Access
- 1 January 2021
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 9 (1) , 62
Clinical manifestations of blood cell parameters and inflammatory factors in 92 patients with COVID-19
Background: Although there are many COVID-19 case series studies, few studies report the relationship between variations in blood cell parameters and inflammatory factors and disease severity. This study aims to describe the dynamic trends in COVID-19 blood cell parameters and inflammatory factors. Methods: Ninety-two patients with confirmed COVID-19 at Jingzhou Central Hospital, Hubei Province, China, between January 23, 2020, and April 10, 2020, were enrolled. Epidemiological data, clinical information, and laboratory test results were collected and analyzed. Results: As patient age increased, disease severity increased (P9/L), but patients with a poor prognosis continued to have a low LYM#. Conclusions: CRP and LYM# showed strong correlation with disease progression, suggesting that these parameters could be used to monitor changes in patient condition.
- 1 January 2021
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 9 (1) , 62
Open AccessClinical manifestations of blood cell parameters and inflammatory factors in 92 patients with COVID-19
Background: Although there are many COVID-19 case series studies, few studies report the relationship between variations in blood cell parameters and inflammatory factors and disease severity. This study aims to describe the dynamic trends in COVID-19 blood cell parameters and inflammatory factors. Methods: Ninety-two patients with confirmed COVID-19 at Jingzhou Central Hospital, Hubei Province, China, between January 23, 2020, and April 10, 2020, were enrolled. Epidemiological data, clinical information, and laboratory test results were collected and analyzed. Results: As patient age increased, disease severity increased (P9/L), but patients with a poor prognosis continued to have a low LYM#. Conclusions: CRP and LYM# showed strong correlation with disease progression, suggesting that these parameters could be used to monitor changes in patient condition.
- 6 September 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
Optimization Arrangement of angle rings in Converter Transformer Valve Winding End Insulation Structure
Angle ring which be placed in the big gap between the winding end and the yoke, could improve the electric field distribution and the insulation reliability of the transformer. Therefore, the optimal arrangement of the angle ring is an important part of the main insulation structure design. In this paper, multi-objective optimization algorithm, particle swarm optimization algorithm and finite element sub-model calculation technology were used to optimize the inside and outside angle rings arrangement of the valve winding end insulation structure, with maintaining the original number, the thickness of the angle rings and arc radius unchanged. During the optimization process, the minimum insulation margin along the electric fluxlines in each assessment oil clearance was selected as the objective function of optimization. The purpose was to make insulation margin along the direction of the electric fluxlines as close as possible among the oil gap. After optimization, it not only made the minimum insulation margin floating range of each assessment clearance smaller, but also increased the minimum insulation margin of the entire end insulation. After optimization, the minimum margin of the outside oil gap increased from 1.35 to 1.54, and the minimum margin of the inside oil gap increased from 1.4 to 1.57.
- 6 September 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
Optimization Arrangement of angle rings in Converter Transformer Valve Winding End Insulation Structure
Angle ring which be placed in the big gap between the winding end and the yoke, could improve the electric field distribution and the insulation reliability of the transformer. Therefore, the optimal arrangement of the angle ring is an important part of the main insulation structure design. In this paper, multi-objective optimization algorithm, particle swarm optimization algorithm and finite element sub-model calculation technology were used to optimize the inside and outside angle rings arrangement of the valve winding end insulation structure, with maintaining the original number, the thickness of the angle rings and arc radius unchanged. During the optimization process, the minimum insulation margin along the electric fluxlines in each assessment oil clearance was selected as the objective function of optimization. The purpose was to make insulation margin along the direction of the electric fluxlines as close as possible among the oil gap. After optimization, it not only made the minimum insulation margin floating range of each assessment clearance smaller, but also increased the minimum insulation margin of the entire end insulation. After optimization, the minimum margin of the outside oil gap increased from 1.35 to 1.54, and the minimum margin of the inside oil gap increased from 1.4 to 1.57.
- 1 September 2016
- Published by Elsevier in Tetrahedron Letters
- Vol. 57 (36) , 4105-4108
PhI(OAc) 2 -mediated decomposition of N -arylsulfonyl hydrazones: metal-free synthesis of ( E )-vinyl sulfones
- 1 September 2016
- Published by Elsevier in Tetrahedron Letters
- Vol. 57 (36) , 4105-4108
PhI(OAc) 2 -mediated decomposition of N -arylsulfonyl hydrazones: metal-free synthesis of ( E )-vinyl sulfones
- Open Access
- 25 July 2015
- Published by Wiley in Cancer Science
- Vol. 106 (10) , 1313-1322
Hematopoietic pre‐B cell leukemia transcription factor interacting protein is overexpressed in gastric cancer and promotes gastric cancer cell proliferation, migration, and invasion
Hematopoietic pre‐B cell leukemia transcription factor interacting protein (HPIP) has been shown to play an important role in the development and progression of some cancers. However, the role of HPIP in gastric cancer (GC) is unclear. Here, we show that HPIP is upregulated in most GC patients and promotes GC cell proliferation, migration, and invasion. In GC patients, HPIP positively associates with tumor size and nodal metastasis, and negatively associates with tumor differentiation. Hematopoietic pre‐B cell leukemia transcription factor interacting protein increases GC cell proliferation through activation of G1/S and G2/M cell cycle transitions, accompanied by a marked increase of the positive cell cycle regulators, including cyclin D1, cyclin A, and cyclin B1. Hematopoietic pre‐B cell leukemia transcription factor interacting protein enhances GC cell migration and invasion, and modulates epithelial–mesenchymal transition, which plays a key role in cancer cell migration and invasion. These data underscore the critical role of HPIP in GC cell proliferation and progression and suggest that HPIP inhibition may be a useful therapeutic strategy for GC treatment.
- 25 July 2015
- Published by Wiley in Cancer Science
- Vol. 106 (10) , 1313-1322
Open AccessHematopoietic pre‐B cell leukemia transcription factor interacting protein is overexpressed in gastric cancer and promotes gastric cancer cell proliferation, migration, and invasion
Hematopoietic pre‐B cell leukemia transcription factor interacting protein (HPIP) has been shown to play an important role in the development and progression of some cancers. However, the role of HPIP in gastric cancer (GC) is unclear. Here, we show that HPIP is upregulated in most GC patients and promotes GC cell proliferation, migration, and invasion. In GC patients, HPIP positively associates with tumor size and nodal metastasis, and negatively associates with tumor differentiation. Hematopoietic pre‐B cell leukemia transcription factor interacting protein increases GC cell proliferation through activation of G1/S and G2/M cell cycle transitions, accompanied by a marked increase of the positive cell cycle regulators, including cyclin D1, cyclin A, and cyclin B1. Hematopoietic pre‐B cell leukemia transcription factor interacting protein enhances GC cell migration and invasion, and modulates epithelial–mesenchymal transition, which plays a key role in cancer cell migration and invasion. These data underscore the critical role of HPIP in GC cell proliferation and progression and suggest that HPIP inhibition may be a useful therapeutic strategy for GC treatment.
- 4 April 2015
- Published by Springer Nature
- p. 629-635
Characteristics of Staphylococcus aureus Isolates from Raw Milk
- 4 April 2015
- Published by Springer Nature
- p. 629-635
Characteristics of Staphylococcus aureus Isolates from Raw Milk